Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Susceptibility-guided vs. Empirical Bismuth Quadruple Therapy for H. Pylori
NCT06200779Phase 4Not yet recruiting
- Start
- Sep 2025
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clarithromycin, levofloxacin in Helicobacter pylori infection. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
clarithromycinlevofloxacin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT06200779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06200779.